Journal
JOURNAL OF CELL COMMUNICATION AND SIGNALING
Volume 17, Issue 3, Pages 409-422Publisher
SPRINGER
DOI: 10.1007/s12079-022-00699-7
Keywords
CXCL17; Chemokine; Cancer; CXCR8
Categories
Ask authors/readers for more resources
Chemokines, including CXCL-17, play diverse roles in cancer pathogenesis. This review investigates the dual role of CXCL-17 in human malignancies and explores potential treatment options in cancer therapy.
Chemokines are immune system mediators that mediate various activities and play a role in the pathogenesis of several cancers. Among these chemokines, C-X-C motif chemokine 17 (CXCL-17) is a relatively novel molecule produced along the airway epithelium in physiological and pathological conditions, and evidence shows that it plays a homeostatic role in most cases. CXCL17 has a protective role in some cancers and a pathological role in others, such as liver and lung cancer. This chemokine, along with its possible receptor termed G protein-coupled receptor 35 (GPR35) or CXCR8, are involved in recruiting myeloid cells, regulating angiogenesis, defending against pathogenic microorganisms, and numerous other mechanisms. Considering the few studies that have been performed on the dual role of CXCL17 in human malignancies, this review has investigated the possible pro-tumor and anti-tumor roles of this chemokine, as well as future treatment options in cancer therapy. [GRAPHICS] .
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available